Home

Suven Pharmaceuticals Ltd EPS

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

EPS

₹ 10.97

Last updated on: Apr 07, 2025

Key Highlights

  • The Earning per Share of Suven Pharmaceuticals Ltd is ₹ 10.97 as of 07 Apr 25 .
  • The earning per share of Suven Pharmaceuticals Ltd changed from ₹ 4.74 to ₹ 3.26 over 7 quarters. This represents a CAGR of -19.26% .

Historical Earning per Share of Suven Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Suven Pharmaceuticals Ltd

Market Cap

26,804 Cr

EPS

11.0

P/E Ratio (TTM)

96.0

P/B Ratio (TTM)

13.6

Day’s High

1074.0

Day’s Low

953.05

DTE

0.0

ROE

12.3

52 Week High

1359.0

52 Week Low

597.0

ROCE

15.3

Market Price of Suven Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Apr 20251052.95
04 Apr 20251086.3
03 Apr 20251125.25
02 Apr 20251093.65
01 Apr 20251074.5
28 Mar 20251159.8
27 Mar 20251109.3
26 Mar 20251113.4
25 Mar 20251151.75
24 Mar 20251173.95

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Suven Pharmaceuticals Ltd

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

26,804

Asset Value

Value addition

53.3 X

494

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Suven Pharmaceuticals Ltd26804
Sun Pharmaceutical Industries Ltd400293
Divis Laboratories Ltd139692
Cipla Ltd111807
Torrent Pharmaceuticals Ltd109399
Mankind Pharma Ltd98130

Historical Market Cap of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Suven Pharmaceuticals Ltd News Hub

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024

Read more

09 Aug 24

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.

Read more

06 Aug 24

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec

Read more

19 Sept 24

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the

Read more

19 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Jan 2025

PPT

June 2024

TranscriptPPT

June 2023

TranscriptPPT

Feb 2023

Transcript

Dec 2022

Transcript

Nov 2022

Transcript

June 2022

Transcript

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

June 2021

TranscriptPPT

FAQs for EPS of Suven Pharmaceuticals Ltd

What is the EPS of Suven Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Suven Pharmaceuticals Ltd is 10.97. An EPS is the amount of net income attributed to each share of a common stock.

How is Suven Pharmaceuticals Ltd EPS calculated?

The EPS of Suven Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Suven Pharmaceuticals Ltd report its EPS?

Suven Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Suven Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Suven Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Suven Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Suven Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions